Century Therapeutics, Inc. (IPSC) Financials

IPSC Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 326.6 million 61.8 million
Dec. 31, 2025 223.7 million 64.8 million
Sept. 30, 2025 244.7 million 68.4 million
June 30, 2025 284.7 million 74.8 million

IPSC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -25.8 million 1.4 million
Dec. 31, 2025 -16.4 million 1.3 million
Sept. 30, 2025 -25.8 million 892000
June 30, 2025 -27.9 million 2.2 million

IPSC Net Income

No data available :(

IPSC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 134.8 million 43.9 million 48.0 million
Dec. 31, 2025 117.1 million - 40.2 million
Sept. 30, 2025 132.7 million - 41.2 million
June 30, 2025 155.8 million - 51.5 million

IPSC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 86.6 million
Dec. 31, 2025 86.6 million
Sept. 30, 2025 86.5 million
June 30, 2025 86.2 million

IPSC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 584000 14.1 million 6.6 million -
Dec. 31, 2025 317000 19.7 million 956000 -
Sept. 30, 2025 195000 22.5 million 6.8 million -
June 30, 2025 317000 26.9 million 7.8 million -

IPSC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 3.0 million
Dec. 31, 2025 - 3.6 million
Sept. 30, 2025 - 3.1 million
June 30, 2025 - 3.2 million

IPSC

Price: $2.13

52 week price:
0.44
3.04

Earnings Per Share: -1.14 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 69234

Market Capitalization: 179.2 million

Links: